Weisblum Eric

Weisblum Eric is listed in filings as Chief Executive Officer at Silo Pharma, Inc.. This profile follows SEC Form 4 activity through Dec 16, 2025, including purchase activity. Recent filings connect the profile to Silo Pharma, Inc. (SILO). The current snapshot covers public activity from Jun 13, 2024 to Dec 16, 2025. Reported amounts are shown as $1.1K to $365. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.